Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

NOF Develops Monodisperse PEG for Antibody Drug Delivery

Filed Under: Industry, Pharma Tagged With: , , , , ,

NOF Corp. (TYO:4403) has developed a monodisperse polyethylene glycol (PEG) as a drug delivery system (DDS) material usable in antibody…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
Coronavirus Report — Part 72: Japanese Research Group Discovers Infection-Suppressing VHH Antibody
Coronavirus Report — Part 72: Japanese Research Group…
Asahi Kasei Advances Into Market for Drug Delivery Systems
Asahi Kasei Advances Into Market for Drug Delivery Systems
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Toray Enables Massive Biopharma Savings With New Continuous Purification System
Toray Enables Massive Biopharma Savings With New Continuous…